Canadian Researchers Examine the Benefits of Translingual Stimulation (PoNS) Combined with Physiotherapy in Multiple Sclerosis
Drs. Michelle Ploughman (Memorial University of Newfoundland) and Sarah Donkers (University of Saskatchewan) are set to lead the first Canadian clinical trial examining…
New ventures lead to new found bonds
Guest post by: Carrie MacLean When I was diagnosed with multiple sclerosis (MS), I thought I only had a few years to live.…
Enjoying the Journey: How to Plan Your Cycling Route
Picture this: it’s a beautiful day, your bike is all tuned up, your helmet is on and you’re ready to hit the open…
Millennials and MS: Abdalla Ahmedin
There are questions about being a millennial with MS that you won’t find answered by a Google search. How do you think about…
Indigenous People and Multiple Sclerosis
Multiple sclerosis (MS) is a disease that does not discriminate – it can affect anyone at any time, often in the prime of their lives. In…
Faces Behind the Science: Kelsi Smith
Kelsi Smith is a Canadian who is pursuing her PhD in the area of neuroscience and epidemiology at Karolinska Insitutet. In 2020, Kelsi…
MS Navigators – pillars of support
A diagnosis of multiple sclerosis (MS) comes with unanswered questions. Your medical team can provide expert advice on halting disease progression and available…
An Unheard Voice: Amplifying Diversity in the MS Community
Guest post by: Moyna John Some days, I feel physically and emotionally fine; other days, I feel severely depressed. I miss when life…
New Developments in MS Research from ACTRIMS Forum 2021
The MS Society of Canada is proud to share new developments in multiple sclerosis (MS) research from the 6th annual Americas Committee for…
The Four Stages of Processing my MS Diagnosis
Alanna’s story may sound familiar, perhaps all too familiar to some. At 25 years old, Alanna Palumbo was your quintessential self-starter: motivated, persistent,…
What is MS?

Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.